Colorectal Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Colorectal Cancer Diagnostics Market By Test (FOB, CTC Tests, CEA Tests, KRAS Mutation Tests, Immunohistochemistry, Others), By End User ( Hospitals, Diagnostic Centers and Cancer Research Institutes) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Colorectal Cancer Diagnostics Market size is expected to grow at a CAGR of  8.8% from 2022 to 2028. Colorectal cancer is also called rectal cancer or colon cancer based on the type of origin in the body. The cancers are very alike in most features. Hence, rectal cancer diagnostics and colon cancer diagnostics are developed and researched on the same outlines as that colorectal cancer. Occurrences of colorectal cancer have been observed a rise over the past decade, which can be due to the aging population, lifestyle disorders, and inappropriate diet habits. The global market provides a detailed overview of the Colorectal Cancer Diagnostics market size, and that can be segmented by test, by end-user, and by Distribution channel. By test, the Colorectal Cancer Diagnostics market growth has been segmented into FOB, CTC Tests, CEA Tests, KRAS Mutation Tests, Immunohistochemistry, and Others. The Fecal Occult Blood (FOB) tests segment is likely to be the largest and fastest-growing segment in terms of tests. The rise of this segment is mainly due to the fact that it is the most accepted test for colorectal cancer diagnostics across the globe.  CTC tests are probably the second largest growing segment in terms of tests. Immunohistochemistry is expected to expand during the forecast period. However, the BRAF tests segment will be expected to account for a comparatively minor share of the global marketplace for colorectal cancer diagnostics during the forecast period. Based on End users, the Colorectal Cancer Diagnostics market is segmented into Hospitals, Diagnostic Centers, and Cancer Research Institutes. Among these, the Hospitals segment is expected to have the fastest-growing market during the forecast period 2022-2028. Most operations are being performed in hospitals due to unremitting patient monitoring devices and care. As hospitals are chief healthcare centers for the people, therefore, superior care, inexpensive treatments, and increasing access are expected to drive the market growth. By region, the North American market is expected to witness the highest market share during the forecast period

Key Developments:

In January 2022, Clinical Genomics announced the extension for 5 years of their supply for the InSure ONE (FIT) fecal immunochemistry test in US

In August 2022, the oncoReveal Dx colon cancer assay developed by Pillar Biosciences got approval from China National Medical Products Administration (NMPA)

Colorectal Cancer Diagnostics Market

MARKET SUMMARY
-
8.8% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR–8.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Colorectal Cancer Diagnostics Market

  • The colorectal cancer diagnostics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The colorectal cancer diagnostics market is segmented based on test, end-user and geography.
Key Players
  • Sysmex Corporation (Japan)
  • Illumina, Inc. (U.S.)
  • Rosetta Genomics Ltd. (U.S.)
  • Danaher Corporation (U.S.)
  • Exact Science Corporation (U.S.)
Colorectal Cancer Diagnostics Market Drivers

The suitable healthcare reimbursement strategies in numerous developed and developing countries are anticipated to propel market growth over the forecast years. Moreover, the need for in-vitro colorectal cancer diagnosis is burgeoning the market growth over the forecast years.


North American Got Significant Share

Colorectal Cancer Diagnostics Market

North American market is expected to witness the highest market share during the forecast period

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Colorectal cancer diagnostics market provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The Colorectal cancer diagnostics market covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The Colorectal cancer diagnostics market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The Colorectal cancer diagnostics market tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The Colorectal cancer diagnostics market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Colorectal Cancer Diagnostics Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The colorectal cancer diagnostics market is projected to expand at a CAGR of 8.8% during the forecast period

Sysmex Corporation (Japan), Illumina, Inc. (U.S.), Rosetta Genomics Ltd. (U.S.), Danaher Corporation (U.S.), Exact Science Corporation (U.S.), Epigenomics AG (Germany), Biocept, Inc. (U.S.), Pathway Genomics Corporation (U.S.), Foundation Medicine, Inc. (U.S.), Cancer Genetics, Inc. (U.S.)

North American is the fastest-growing region for colorectal cancer diagnostics market


Report

Table Of Content

  1. Executive Summary
  2. Global Colorectal Cancer Diagnostics Market Introduction
    • Global Colorectal Cancer Diagnostics Market – Taxonomy
    • Global Colorectal Cancer Diagnostics Market –Definitions
      • Test
      • End User
  1. Global Colorectal Cancer Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Colorectal Cancer Diagnostics Market Dynamic Factors – Impact Analysis
    • Global Colorectal Cancer Diagnostics Market – Competition Landscape
    • Epidemiology
  2. Global Colorectal Cancer Diagnostics Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Colorectal Cancer Diagnostics Market, By Test, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • FOB
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CEA Tests
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • CTC Tests
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immunohistochemistry
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • KRAS Mutation Tests
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Colorectal Cancer Diagnostics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cancer Research Institutes
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Colorectal Cancer Diagnostics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Region, 2020 – 2026
  2. North America Colorectal Cancer Diagnostics MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • FOB
      • CEA Tests
      • CTC Tests
      • Immunohistochemistry
      • KRAS Mutation Tests
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Cancer Research Institutes
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Country, 2020 – 2026
    • North America Colorectal Cancer Diagnostics Market Dynamics – Trends
  3. Europe Colorectal Cancer Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • FOB
      • CEA Tests
      • CTC Tests
      • Immunohistochemistry
      • KRAS Mutation Tests
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Country, 2020 – 2026
    • Europe Colorectal Cancer Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Colorectal Cancer Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • FOB
      • CEA Tests
      • CTC Tests
      • Immunohistochemistry
      • KRAS Mutation Tests
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Cancer Research Institutes
    • Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Country, 2020 – 2026
    • Asia-Pacific Colorectal Cancer Diagnostics Market Dynamics – Trends
  5. Latin America Colorectal Cancer Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • FOB
      • CEA Tests
      • CTC Tests
      • Immunohistochemistry
      • KRAS Mutation Tests
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Country, 2020 – 2026
    • Latin America Colorectal Cancer Diagnostics Market Dynamics – Trends
  6. Middle East and Africa Colorectal Cancer Diagnostics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • FOB
      • CEA Tests
      • CTC Tests
      • Immunohistochemistry
      • KRAS Mutation Tests
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Diagnostic Centers
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Colorectal Cancer Diagnostics Market – Opportunity Analysis Index, By Test, By End User, and Country, 2020 – 2026
    • MEA Colorectal Cancer Diagnostics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Test& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Sysmex Corporation (Japan)
      • Illumina, Inc. (U.S.)
      • Rosetta Genomics Ltd. (U.S.)
      • Danaher Corporation (U.S.)
      • Exact Science Corporation (U.S.)
      • Epigenomics AG (Germany)
      • Biocept, Inc. (U.S.)
      • Pathway Genomics Corporation (U.S.)
      • Foundation Medicine, Inc. (U.S.)
      • Cancer Genetics, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Sysmex Corporation (Japan)
  • Illumina, Inc. (U.S.)
  • Rosetta Genomics Ltd. (U.S.)
  • Danaher Corporation (U.S.)
  • Exact Science Corporation (U.S.)
  • Epigenomics AG (Germany)
  • Biocept, Inc. (U.S.)
  • Pathway Genomics Corporation (U.S.)
  • Foundation Medicine, Inc. (U.S.)
  • Cancer Genetics, Inc. (U.S.)

Report

Report Customisation

Description

Colorectal Cancer Diagnostics Market size is expected to grow at a CAGR of  8.8% from 2022 to 2028. Colorectal cancer is also called rectal cancer or colon cancer based on the type of origin in the body. The cancers are very alike in most features. Hence, rectal cancer diagnostics and colon cancer diagnostics are developed and researched on the same outlines as that colorectal cancer. Occurrences of colorectal cancer have been observed a rise over the past decade, which can be due to the aging population, lifestyle disorders, and inappropriate diet habits. The global market provides a detailed overview of the Colorectal Cancer Diagnostics market size, and that can be segmented by test, by end-user, and by Distribution channel. By test, the Colorectal Cancer Diagnostics market growth has been segmented into FOB, CTC Tests, CEA Tests, KRAS Mutation Tests, Immunohistochemistry, and Others. The Fecal Occult Blood (FOB) tests segment is likely to be the largest and fastest-growing segment in terms of tests. The rise of this segment is mainly due to the fact that it is the most accepted test for colorectal cancer diagnostics across the globe.  CTC tests are probably the second largest growing segment in terms of tests. Immunohistochemistry is expected to expand during the forecast period. However, the BRAF tests segment will be expected to account for a comparatively minor share of the global marketplace for colorectal cancer diagnostics during the forecast period. Based on End users, the Colorectal Cancer Diagnostics market is segmented into Hospitals, Diagnostic Centers, and Cancer Research Institutes. Among these, the Hospitals segment is expected to have the fastest-growing market during the forecast period 2022-2028. Most operations are being performed in hospitals due to unremitting patient monitoring devices and care. As hospitals are chief healthcare centers for the people, therefore, superior care, inexpensive treatments, and increasing access are expected to drive the market growth. By region, the North American market is expected to witness the highest market share during the forecast period

Key Developments:

In January 2022, Clinical Genomics announced the extension for 5 years of their supply for the InSure ONE (FIT) fecal immunochemistry test in US

In August 2022, the oncoReveal Dx colon cancer assay developed by Pillar Biosciences got approval from China National Medical Products Administration (NMPA)

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX